11/22
07:52 am
amph
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $55.00 price target on the stock.
Low
Report
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $55.00 price target on the stock.
11/13
04:05 pm
amph
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Low
Report
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
11/7
02:31 am
amph
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ... [Yahoo! Finance]
Medium
Report
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ... [Yahoo! Finance]
11/6
07:28 pm
amph
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings [Yahoo! Finance]
Medium
Report
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings [Yahoo! Finance]
11/6
04:05 pm
amph
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024
High
Report
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024
11/5
07:56 am
amph
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect [Yahoo! Finance]
Low
Report
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect [Yahoo! Finance]
11/1
11:06 pm
amph
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
10/29
06:00 am
amph
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024
Low
Report
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024
10/18
01:48 pm
amph
Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]
Low
Report
Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]
10/18
02:06 am
amph
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
10/16
12:12 pm
amph
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals? [Yahoo! Finance]
Low
Report
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals? [Yahoo! Finance]
10/10
11:22 pm
amph
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
10/3
10:09 am
amph
Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options [Yahoo! Finance]
Low
Report
Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options [Yahoo! Finance]
9/20
02:37 am
amph
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
9/19
11:43 am
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns [Yahoo! Finance]
Low
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns [Yahoo! Finance]
9/12
11:06 pm
amph
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
9/6
10:10 am
amph
Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma Sep. 06, 2024 8:39 AM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]
Low
Report
Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma Sep. 06, 2024 8:39 AM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]
9/2
02:11 am
amph
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
8/28
04:25 pm
amph
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference [Yahoo! Finance]
Low
Report
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference [Yahoo! Finance]
8/28
04:10 pm
amph
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
Low
Report
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
8/25
02:06 am
amph
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.